Relationship Between Dose and Local Control in Five-fraction Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
PTV D95% was a significant prognostic factor for LC in patients with HCC treated with five-fraction SBRT. These findings suggest that PTV D95% ≥40 Gy should be considered as a cut-off dose to prevent recurrence.
Authors
- Yuki Mukai (ORCID: https://orcid.org/0000-0002-0000-1199)
- Yasuhiro Takeda (ORCID: https://orcid.org/0000-0002-1429-5060)
- Yuta Nishikawa
- Ichiro Ogino (ORCID: https://orcid.org/0000-0003-0437-8150)
- Akihiro Funaoka
- Masaharu Hata
Institutions
- Yokohama City University Medical Center (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-08-28
- DOI
- https://doi.org/10.21873/invivo.14090
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00